HFrEF

Advertisement
DocWire News EditorsCardiology | August 21, 2020
Sacubitril-valsartan administration was cost-effective and associated with benefit in patients hospitalized with heart ...
Read More
DocWire News EditorsCardiology | April 3, 2020
There is more COVID news in this week's Round-up, including an interview with Dr. Carl J. "Chip" Lavie about some ...
DocWire News EditorsHeart Failure | May 2, 2023
Dapagliflozin reduced cardiovascular morbidity and mortality in patients with heart failure with reduced ejection ...
Advertisement
Advertisement